EC50 values of selinexor or venetoclax monotherapies in lymphoma cell lines (Figure 1A) revealed that XPO1 mutant cells SUDHL‐16 XPO1 E571K were significantly more sensitive to selinexor (EC50 = 24 nM) when compared to XPO1 wild‐type (WT) cell lines SUDHL‐6 and Farage (EC50 = 144 nM and 41 nM, respectively). The gene discussed is XPO1; the disease is lymphoma.